Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0002665 | HP:0002665 | Lymphoma | 0 | AAGAB CL E G H | 79719 | 25662 | ORPHA:79501 | Punctate palmoplantar keratoderma type 1 | | | | 7 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | ADA CL E G H | 100 | 186 | ORPHA:39041 | Omenn syndrome | HP:0040283 - Occasional | | | 75 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | ADA CL E G H | 100 | 186 | OMIM:102700 | Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency | | | | 75 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | APC CL E G H | 324 | 583 | ORPHA:99818 | Turcot syndrome with polyposis | HP:0040284 - Very rare | | | 3179 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | ASXL1 CL E G H | 171023 | 18318 | ORPHA:98849 | Systemic mastocytosis with associated hematologic neoplasm | HP:0040283 - Occasional | | | 145 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | ATM CL E G H | 472 | 795 | OMIM:208900 | ATAXIA-TELANGIECTASIA | . | | | 3267 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | ATM CL E G H | 472 | 795 | ORPHA:52416 | Mantle cell lymphoma | | | | 3267 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | BCL10 CL E G H | 8915 | 989 | OMIM:137245 | Gastric lymphoma, primary | | | | 18 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | BCL10 CL E G H | 8915 | 989 | OMIM:605027 | Lymphoma, non-hodgkin, familial | . | | | 18 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | BCL10 CL E G H | 8915 | 989 | ORPHA:52417 | MALT lymphoma | | | | 18 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | BCL2 CL E G H | 596 | 990 | ORPHA:545 | Follicular lymphoma | HP:0040281 - Very frequent | | | 1 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | BCL6 CL E G H | 604 | 1001 | ORPHA:545 | Follicular lymphoma | HP:0040281 - Very frequent | | | 1 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | BIRC3 CL E G H | 330 | 591 | ORPHA:52417 | MALT lymphoma | | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | BLM CL E G H | 641 | 1058 | ORPHA:125 | Bloom syndrome | HP:0040283 - Occasional | | | 314 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | BLM CL E G H | 641 | 1058 | OMIM:210900 | Bloom syndrome | . | | | 314 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CASP10 CL E G H | 843 | 1500 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | 87 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CASP10 CL E G H | 843 | 1500 | OMIM:605027 | Lymphoma, non-hodgkin, familial | . | | | 87 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CCND1 CL E G H | 595 | 1582 | ORPHA:52416 | Mantle cell lymphoma | | | | 1 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CD19 CL E G H | 930 | 1633 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 38 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CD19 CL E G H | 930 | 1633 | OMIM:240500 | Immunodeficiency, common variable, 2 | . | | | 38 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CD27 CL E G H | 939 | 11922 | OMIM:615122 | Lymphoproliferative syndrome 2 | | | | 4 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CD28 CL E G H | 940 | 1653 | ORPHA:2584 | Classic mycosis fungoides | HP:0040281 - Very frequent | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CD28 CL E G H | 940 | 1653 | ORPHA:3162 | Sézary syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CD70 CL E G H | 970 | 11937 | OMIM:618261 | LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3 | | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CD81 CL E G H | 975 | 1701 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 1 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CDKN2A CL E G H | 1029 | 1787 | ORPHA:524 | Li-Fraumeni syndrome | HP:0040283 - Occasional | | | 289 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CHD7 CL E G H | 55636 | 20626 | ORPHA:39041 | Omenn syndrome | HP:0040283 - Occasional | | | 515 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CHEK2 CL E G H | 11200 | 16627 | ORPHA:524 | Li-Fraumeni syndrome | HP:0040283 - Occasional | | | 833 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | COL14A1 CL E G H | 7373 | 2191 | ORPHA:79501 | Punctate palmoplantar keratoderma type 1 | | | | 2 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CR2 CL E G H | 1380 | 2336 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 10 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CR2 CL E G H | 1380 | 2336 | OMIM:240500 | Immunodeficiency, common variable, 2 | . | | | 10 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CTC1 CL E G H | 80169 | 26169 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 160 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:2584 | Classic mycosis fungoides | HP:0040281 - Very frequent | | | 10 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:3162 | Sézary syndrome | HP:0040281 - Very frequent | | | 10 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | DCLRE1C CL E G H | 64421 | 17642 | ORPHA:39041 | Omenn syndrome | HP:0040283 - Occasional | | | 94 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | DDX41 CL E G H | 51428 | 18674 | OMIM:616871 | Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to | . | | | 23 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | DEF6 CL E G H | 50619 | 2760 | OMIM:619573 | IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87 | | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | DKC1 CL E G H | 1736 | 2890 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 65 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | DKC1 CL E G H | 1736 | 2890 | OMIM:305000 | Dyskeratosis congenita, X-linked | | | | 65 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | DNASE1L3 CL E G H | 1776 | 2959 | ORPHA:36412 | Hypocomplementemic urticarial vasculitis | HP:0040283 - Occasional | | | 3 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | FAS CL E G H | 355 | 11920 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | 59 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | FASLG CL E G H | 356 | 11936 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | 37 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | FCHO1 CL E G H | 23149 | 29002 | OMIM:619164 | IMMUNODEFICIENCY 76; IMD76 | | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | FOXP1 CL E G H | 27086 | 3823 | ORPHA:52417 | MALT lymphoma | | | | 184 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | HLA-DQA1 CL E G H | 3117 | 4942 | OMIM:212750 | Celiac disease, susceptibility to, 1 | . | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | HLA-DQB1 CL E G H | 3119 | 4944 | OMIM:212750 | Celiac disease, susceptibility to, 1 | . | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:545 | Follicular lymphoma | HP:0040281 - Very frequent | | | 2 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | ICOS CL E G H | 29851 | 5351 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 32 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | ICOS CL E G H | 29851 | 5351 | OMIM:240500 | Immunodeficiency, common variable, 2 | . | | | 32 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | IGH CL E G H | 3492 | 5477 | ORPHA:545 | Follicular lymphoma | HP:0040281 - Very frequent | | | 7 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | IGH CL E G H | 3492 | 5477 | ORPHA:52417 | MALT lymphoma | | | | 7 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | IGH CL E G H | 3492 | 5477 | ORPHA:52416 | Mantle cell lymphoma | | | | 7 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | IGHG2 CL E G H | 3501 | 5526 | ORPHA:183675 | Recurrent infections associated with rare immunoglobulin isotypes deficiency | | | | 1 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | IGKC CL E G H | 3514 | 5716 | ORPHA:183675 | Recurrent infections associated with rare immunoglobulin isotypes deficiency | | | | 5 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | IKZF3 CL E G H | 22806 | 13178 | OMIM:619437 | IMMUNODEFICIENCY 84; IMD84 | | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | IL2RG CL E G H | 3561 | 6010 | ORPHA:39041 | Omenn syndrome | HP:0040283 - Occasional | | | 48 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | IL2RG CL E G H | 3561 | 6010 | ORPHA:276 | T-B+ severe combined immunodeficiency due to gamma chain deficiency | HP:0040284 - Very rare | | | 48 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | IL7R CL E G H | 3575 | 6024 | ORPHA:39041 | Omenn syndrome | HP:0040283 - Occasional | | | 94 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 4 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | ITK CL E G H | 3702 | 6171 | OMIM:613011 | LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1 | | | | 51 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | KIF11 CL E G H | 3832 | 6388 | ORPHA:2526 | Microcephaly-lymphedema-chorioretinopathy syndrome | HP:0040283 - Occasional | | | 46 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | KIT CL E G H | 3815 | 6342 | ORPHA:98849 | Systemic mastocytosis with associated hematologic neoplasm | HP:0040283 - Occasional | | | 327 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | KLHDC8B CL E G H | 200942 | 28557 | OMIM:236000 | Lymphoma, hodgkin | | | | 1 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | KRAS CL E G H | 3845 | 6407 | OMIM:614470 | RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic | . | | | 196 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | LIG4 CL E G H | 3981 | 6601 | ORPHA:235 | Dubowitz syndrome | HP:0040283 - Occasional | | | 88 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | LIG4 CL E G H | 3981 | 6601 | ORPHA:99812 | LIG4 syndrome | HP:0040282 - Frequent | | | 88 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | LIG4 CL E G H | 3981 | 6601 | ORPHA:39041 | Omenn syndrome | HP:0040283 - Occasional | | | 88 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | LRBA CL E G H | 987 | 1742 | OMIM:614700 | IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8 | | | | 45 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | MAGT1 CL E G H | 84061 | 28880 | OMIM:300853 | IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN | | | | 17 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | MALT1 CL E G H | 10892 | 6819 | ORPHA:52417 | MALT lymphoma | | | | 6 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | MDM2 CL E G H | 4193 | 6973 | ORPHA:524 | Li-Fraumeni syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | MLH1 CL E G H | 4292 | 7127 | OMIM:276300 | Mismatch repair cancer syndrome 1 | | | | 1819 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | MS4A1 CL E G H | 931 | 7315 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 1 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | MSH6 CL E G H | 2956 | 7329 | OMIM:619097 | MISMATCH REPAIR CANCER SYNDROME 3; MMRCS3 | | | | 2232 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | MYC CL E G H | 4609 | 7553 | OMIM:113970 | Burkitt lymphoma | | | | 11 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | MYD88 CL E G H | 4615 | 7562 | OMIM:153600 | Macroglobulinemia, Waldenstrom, somatic | HP:0040283 - Occasional | | | 9 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | MYD88 CL E G H | 4615 | 7562 | ORPHA:33226 | Waldenström macroglobulinemia | HP:0040281 - Very frequent | | | 9 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | NBN CL E G H | 4683 | 7652 | OMIM:251260 | Nijmegen breakage syndrome | . | | | 706 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | NBN CL E G H | 4683 | 7652 | ORPHA:647 | Nijmegen breakage syndrome | HP:0040283 - Occasional | | | 706 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | NFKB1 CL E G H | 4790 | 7794 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 7 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 11 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | NHP2 CL E G H | 55651 | 14377 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 27 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | NOP10 CL E G H | 55505 | 14378 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 17 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | NPM1 CL E G H | 4869 | 7910 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 12 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | NRAS CL E G H | 4893 | 7989 | OMIM:614470 | RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic | . | | | 102 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | NSUN2 CL E G H | 54888 | 25994 | ORPHA:235 | Dubowitz syndrome | HP:0040283 - Occasional | | | 84 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | NTHL1 CL E G H | 4913 | 8028 | ORPHA:454840 | NTHL1-related attenuated familial adenomatous polyposis | | | | 2 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | PARN CL E G H | 5073 | 8609 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 26 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | PGM3 CL E G H | 5238 | 8907 | OMIM:615816 | Immunodeficiency 23 | | | | 15 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | PGM3 CL E G H | 5238 | 8907 | ORPHA:443811 | PGM3-CDG | HP:0040283 - Occasional | | | 15 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | PIK3R1 CL E G H | 5295 | 8979 | OMIM:616005 | Immunodeficiency 36 | | | | 43 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | PMS2 CL E G H | 5395 | 9122 | OMIM:619101 | MISMATCH REPAIR CANCER SYNDROME 4; MMRCS4 | | | | 1121 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | PNP CL E G H | 4860 | 7892 | OMIM:613179 | Immunodeficiency due to purine nucleoside phosphorylase deficiency | . | | | 52 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | POLE CL E G H | 5426 | 9177 | OMIM:618336 | Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency | | | | 1129 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | PRF1 CL E G H | 5551 | 9360 | OMIM:605027 | Lymphoma, non-hodgkin, familial | . | | | 58 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | PRKCD CL E G H | 5580 | 9399 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | 10 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | PRKCD CL E G H | 5580 | 9399 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 10 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | PTEN CL E G H | 5728 | 9588 | ORPHA:109 | Bannayan-Riley-Ruvalcaba syndrome | HP:0040283 - Occasional | | | 948 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | PTPRC CL E G H | 5788 | 9666 | OMIM:619924 | | | | | 25 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RAD54B CL E G H | 25788 | 17228 | OMIM:605027 | Lymphoma, non-hodgkin, familial | . | | | 2 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RAD54L CL E G H | 8438 | 9826 | OMIM:605027 | Lymphoma, non-hodgkin, familial | . | | | 5 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RAG1 CL E G H | 5896 | 9831 | ORPHA:39041 | Omenn syndrome | HP:0040283 - Occasional | | | 127 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RAG2 CL E G H | 5897 | 9832 | ORPHA:39041 | Omenn syndrome | HP:0040283 - Occasional | | | 50 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RASGRP1 CL E G H | 10125 | 9878 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RASGRP1 CL E G H | 10125 | 9878 | OMIM:618534 | IMMUNODEFICIENCY 64; IMD64 | | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RB1 CL E G H | 5925 | 9884 | OMIM:180200 | RETINOBLASTOMA | . | | | 365 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RECQL4 CL E G H | 9401 | 9949 | ORPHA:1225 | Baller-Gerold syndrome | HP:0040283 - Occasional | | | 445 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RECQL4 CL E G H | 9401 | 9949 | ORPHA:221016 | Rothmund-Thomson syndrome type 2 | HP:0040283 - Occasional | | | 445 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RHOH CL E G H | 399 | 686 | OMIM:618307 | Epidermodysplasia verruciformis, susceptibility to, 4 | | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RMRP CL E G H | 6023 | 10031 | OMIM:250250 | Cartilage-Hair hypoplasia | | | | 37 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RMRP CL E G H | 6023 | 10031 | ORPHA:39041 | Omenn syndrome | HP:0040283 - Occasional | | | 37 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RNF43 CL E G H | 54894 | 18505 | ORPHA:157798 | Serrated polyposis syndrome | | | | 5 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RTEL1 CL E G H | 51750 | 15888 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 77 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | RUNX1 CL E G H | 861 | 10471 | OMIM:601399 | Platelet disorder, familial, with associated myeloid malignancy | . | | | 181 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | SH2D1A CL E G H | 4068 | 10820 | OMIM:308240 | Lymphoproliferative syndrome, X-linked, 1 | | | | 37 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | SMARCAL1 CL E G H | 50485 | 11102 | ORPHA:1830 | Schimke immuno-osseous dysplasia | | | | 74 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | SOCS1 CL E G H | 8651 | 19383 | OMIM:619375 | AUTOINFLAMMATORY SYNDROME, FAMILIAL, WITH OR WITHOUT IMMUNODEFICIENCY; AISIMD | | | | 6 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | SRSF2 CL E G H | 6427 | 10783 | ORPHA:98849 | Systemic mastocytosis with associated hematologic neoplasm | HP:0040283 - Occasional | | | 1 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | STAT3 CL E G H | 6774 | 11364 | OMIM:615952 | AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1 | | | | 110 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | STAT3 CL E G H | 6774 | 11364 | ORPHA:2314 | Autosomal dominant hyper-IgE syndrome | HP:0040283 - Occasional | | | 110 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | SYK CL E G H | 6850 | 11491 | OMIM:619381 | IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD82 | | | | 1 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TCF4 CL E G H | 6925 | 11634 | ORPHA:2896 | Pitt-Hopkins syndrome | | | | 241 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TERC CL E G H | 7012 | 11727 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 48 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 238 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TET2 CL E G H | 54790 | 25941 | OMIM:619126 | IMMUNODEFICIENCY 75; IMD75 | | | | 3 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TET2 CL E G H | 54790 | 25941 | ORPHA:98849 | Systemic mastocytosis with associated hematologic neoplasm | HP:0040283 - Occasional | | | 3 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TINF2 CL E G H | 26277 | 11824 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 60 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TNFRSF13B CL E G H | 23495 | 18153 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 32 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TNFRSF13B CL E G H | 23495 | 18153 | OMIM:240500 | Immunodeficiency, common variable, 2 | . | | | 32 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TNFRSF13C CL E G H | 115650 | 17755 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 12 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TNFRSF13C CL E G H | 115650 | 17755 | OMIM:240500 | Immunodeficiency, common variable, 2 | . | | | 12 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TNFRSF1B CL E G H | 7133 | 11917 | ORPHA:2584 | Classic mycosis fungoides | HP:0040281 - Very frequent | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TNFRSF1B CL E G H | 7133 | 11917 | ORPHA:3162 | Sézary syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TNFSF12 CL E G H | 8742 | 11927 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 1 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TP53 CL E G H | 7157 | 11998 | ORPHA:524 | Li-Fraumeni syndrome | HP:0040283 - Occasional | | | 911 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TP63 CL E G H | 8626 | 15979 | ORPHA:1896 | EEC syndrome | HP:0040283 - Occasional | | | 140 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TTC7A CL E G H | 57217 | 19750 | OMIM:243150 | Gastrointestinal defects and immunodeficiency syndrome | | | | 26 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | TYMS CL E G H | 7298 | 12441 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 1 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | USB1 CL E G H | 79650 | 25792 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 8 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | WAS CL E G H | 7454 | 12731 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040283 - Occasional | | | 65 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | WIPF1 CL E G H | 7456 | 12736 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040283 - Occasional | | | 6 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | WRAP53 CL E G H | 55135 | 25522 | ORPHA:1775 | Dyskeratosis congenita | HP:0040283 - Occasional | | | 40 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | XIAP CL E G H | 331 | 592 | OMIM:308240 | Lymphoproliferative syndrome, X-linked, 1 | | | | 81 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | XRCC4 CL E G H | 7518 | 12831 | ORPHA:99812 | LIG4 syndrome | HP:0040282 - Frequent | | | 9 | | |
HP:0002665 | HP:0002665 | Lymphoma | 0 | ZAP70 CL E G H | 7535 | 12858 | ORPHA:911 | Combined immunodeficiency due to ZAP70 deficiency | HP:0040284 - Very rare | | | 46 | | |
HP:0002665 | HP:0011953 | Pulmonary lymphoma | 1 | CL E G H | | | | | | | | | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | AAGAB CL E G H | 79719 | 25662 | ORPHA:79501 | Punctate palmoplantar keratoderma type 1 | HP:0040284 - Very rare | | | 7 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | ADA CL E G H | 100 | 186 | OMIM:102700 | Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency | | | | 75 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | ATM CL E G H | 472 | 795 | OMIM:208900 | ATAXIA-TELANGIECTASIA | . | | | 3267 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | ATM CL E G H | 472 | 795 | OMIM:208900 | ATAXIA-TELANGIECTASIA | . | | | 3267 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | ATM CL E G H | 472 | 795 | ORPHA:52416 | Mantle cell lymphoma | | | | 3267 | | |
HP:0002665 | HP:0045038 | Gastric lymphoma | 1 | BCL10 CL E G H | 8915 | 989 | OMIM:137245 | Gastric lymphoma, primary | . | | | 18 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | BCL10 CL E G H | 8915 | 989 | ORPHA:52417 | MALT lymphoma | | | | 18 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | BIRC3 CL E G H | 330 | 591 | ORPHA:52417 | MALT lymphoma | | | | | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | CASP10 CL E G H | 843 | 1500 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 87 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | CASP10 CL E G H | 843 | 1500 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 87 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | CCND1 CL E G H | 595 | 1582 | ORPHA:52416 | Mantle cell lymphoma | | | | 1 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | CD27 CL E G H | 939 | 11922 | OMIM:615122 | Lymphoproliferative syndrome 2 | | | | 4 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | CD28 CL E G H | 940 | 1653 | ORPHA:2584 | Classic mycosis fungoides | | | | | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | CD28 CL E G H | 940 | 1653 | ORPHA:3162 | Sézary syndrome | | | | | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | CD70 CL E G H | 970 | 11937 | OMIM:618261 | LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3 | | | | | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | CDKN2A CL E G H | 1029 | 1787 | ORPHA:524 | Li-Fraumeni syndrome | HP:0040284 - Very rare | | | 289 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | CDKN2A CL E G H | 1029 | 1787 | ORPHA:524 | Li-Fraumeni syndrome | HP:0040284 - Very rare | | | 289 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | CHEK2 CL E G H | 11200 | 16627 | ORPHA:524 | Li-Fraumeni syndrome | HP:0040284 - Very rare | | | 833 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | CHEK2 CL E G H | 11200 | 16627 | ORPHA:524 | Li-Fraumeni syndrome | HP:0040284 - Very rare | | | 833 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | COL14A1 CL E G H | 7373 | 2191 | ORPHA:79501 | Punctate palmoplantar keratoderma type 1 | HP:0040284 - Very rare | | | 2 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:2584 | Classic mycosis fungoides | | | | 10 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:3162 | Sézary syndrome | | | | 10 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | DEF6 CL E G H | 50619 | 2760 | OMIM:619573 | IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87 | | | | | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | DKC1 CL E G H | 1736 | 2890 | OMIM:305000 | Dyskeratosis congenita, X-linked | . | | | 65 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | FAS CL E G H | 355 | 11920 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 59 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | FAS CL E G H | 355 | 11920 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 59 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | FASLG CL E G H | 356 | 11936 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 37 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | FASLG CL E G H | 356 | 11936 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 37 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | FCHO1 CL E G H | 23149 | 29002 | OMIM:619164 | IMMUNODEFICIENCY 76; IMD76 | | | | | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | FOXP1 CL E G H | 27086 | 3823 | ORPHA:52417 | MALT lymphoma | | | | 184 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | IGH CL E G H | 3492 | 5477 | ORPHA:52417 | MALT lymphoma | | | | 7 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | IGH CL E G H | 3492 | 5477 | ORPHA:52416 | Mantle cell lymphoma | | | | 7 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | IKZF3 CL E G H | 22806 | 13178 | OMIM:619437 | IMMUNODEFICIENCY 84; IMD84 | | | | | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | ITK CL E G H | 3702 | 6171 | OMIM:613011 | LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1 | | | | 51 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | ITK CL E G H | 3702 | 6171 | OMIM:613011 | LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1 | | | | 51 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | KLHDC8B CL E G H | 200942 | 28557 | OMIM:236000 | Lymphoma, hodgkin | . | | | 1 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | MAGT1 CL E G H | 84061 | 28880 | OMIM:300853 | IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN | | | | 17 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | MAGT1 CL E G H | 84061 | 28880 | OMIM:300853 | IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN | | | | 17 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | MALT1 CL E G H | 10892 | 6819 | ORPHA:52417 | MALT lymphoma | | | | 6 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | MDM2 CL E G H | 4193 | 6973 | ORPHA:524 | Li-Fraumeni syndrome | HP:0040284 - Very rare | | | 1 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | MDM2 CL E G H | 4193 | 6973 | ORPHA:524 | Li-Fraumeni syndrome | HP:0040284 - Very rare | | | 1 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | MLH1 CL E G H | 4292 | 7127 | OMIM:276300 | Mismatch repair cancer syndrome 1 | | | | 1819 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | MSH6 CL E G H | 2956 | 7329 | OMIM:619097 | MISMATCH REPAIR CANCER SYNDROME 3; MMRCS3 | | | | 2232 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | MYC CL E G H | 4609 | 7553 | OMIM:113970 | Burkitt lymphoma | | | | 11 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | NBN CL E G H | 4683 | 7652 | ORPHA:647 | Nijmegen breakage syndrome | | | | 706 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | NTHL1 CL E G H | 4913 | 8028 | ORPHA:454840 | NTHL1-related attenuated familial adenomatous polyposis | HP:0040283 - Occasional | | | 2 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | PGM3 CL E G H | 5238 | 8907 | OMIM:615816 | Immunodeficiency 23 | | | | 15 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | PIK3R1 CL E G H | 5295 | 8979 | OMIM:616005 | Immunodeficiency 36 | | | | 43 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | PMS2 CL E G H | 5395 | 9122 | OMIM:619101 | MISMATCH REPAIR CANCER SYNDROME 4; MMRCS4 | | | | 1121 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | POLE CL E G H | 5426 | 9177 | OMIM:618336 | Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency | HP:0040284 - Very rare | | | 1129 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | POLE CL E G H | 5426 | 9177 | OMIM:618336 | Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency | | | | 1129 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | PRKCD CL E G H | 5580 | 9399 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 10 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | PRKCD CL E G H | 5580 | 9399 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 10 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | PTPRC CL E G H | 5788 | 9666 | OMIM:619924 | | | | | 25 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | RASGRP1 CL E G H | 10125 | 9878 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | RASGRP1 CL E G H | 10125 | 9878 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | RASGRP1 CL E G H | 10125 | 9878 | OMIM:618534 | IMMUNODEFICIENCY 64; IMD64 | | | | | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | RHOH CL E G H | 399 | 686 | OMIM:618307 | Epidermodysplasia verruciformis, susceptibility to, 4 | | | | | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | RNF43 CL E G H | 54894 | 18505 | ORPHA:157798 | Serrated polyposis syndrome | HP:0040284 - Very rare | | | 5 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | SH2D1A CL E G H | 4068 | 10820 | OMIM:308240 | Lymphoproliferative syndrome, X-linked, 1 | | | | 37 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | SMARCAL1 CL E G H | 50485 | 11102 | ORPHA:1830 | Schimke immuno-osseous dysplasia | HP:0040284 - Very rare | | | 74 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | SOCS1 CL E G H | 8651 | 19383 | OMIM:619375 | AUTOINFLAMMATORY SYNDROME, FAMILIAL, WITH OR WITHOUT IMMUNODEFICIENCY; AISIMD | | | | 6 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | STAT3 CL E G H | 6774 | 11364 | OMIM:615952 | AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1 | | | | 110 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | SYK CL E G H | 6850 | 11491 | OMIM:619381 | IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD82 | | | | 1 | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | TCF4 CL E G H | 6925 | 11634 | ORPHA:2896 | Pitt-Hopkins syndrome | HP:0040284 - Very rare | | | 241 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | TNFRSF1B CL E G H | 7133 | 11917 | ORPHA:2584 | Classic mycosis fungoides | | | | | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | TNFRSF1B CL E G H | 7133 | 11917 | ORPHA:3162 | Sézary syndrome | | | | | | |
HP:0002665 | HP:0012189 | Hodgkin lymphoma | 1 | TP53 CL E G H | 7157 | 11998 | ORPHA:524 | Li-Fraumeni syndrome | HP:0040284 - Very rare | | | 911 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | TP53 CL E G H | 7157 | 11998 | ORPHA:524 | Li-Fraumeni syndrome | HP:0040284 - Very rare | | | 911 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | TTC7A CL E G H | 57217 | 19750 | OMIM:243150 | Gastrointestinal defects and immunodeficiency syndrome | | | | 26 | | |
HP:0002665 | HP:0012539 | Non-Hodgkin lymphoma | 1 | XIAP CL E G H | 331 | 592 | OMIM:308240 | Lymphoproliferative syndrome, X-linked, 1 | | | | 81 | | |
HP:0002665 | HP:0030069 | Primary central nervous system lymphoma | 2 | CL E G H | | | | | | | | | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | ADA CL E G H | 100 | 186 | OMIM:102700 | Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency | . | | | 75 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | ATM CL E G H | 472 | 795 | ORPHA:52416 | Mantle cell lymphoma | HP:0040281 - Very frequent | | | 3267 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | BCL10 CL E G H | 8915 | 989 | ORPHA:52417 | MALT lymphoma | HP:0040281 - Very frequent | | | 18 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | BIRC3 CL E G H | 330 | 591 | ORPHA:52417 | MALT lymphoma | HP:0040281 - Very frequent | | | | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | CASP10 CL E G H | 843 | 1500 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 87 | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | CASP10 CL E G H | 843 | 1500 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 87 | | |
HP:0002665 | HP:0030080 | Burkitt lymphoma | 2 | CASP10 CL E G H | 843 | 1500 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 87 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | CCND1 CL E G H | 595 | 1582 | ORPHA:52416 | Mantle cell lymphoma | HP:0040281 - Very frequent | | | 1 | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | CD28 CL E G H | 940 | 1653 | ORPHA:2584 | Classic mycosis fungoides | | | | | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | CD28 CL E G H | 940 | 1653 | ORPHA:3162 | Sézary syndrome | | | | | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:2584 | Classic mycosis fungoides | | | | 10 | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:3162 | Sézary syndrome | | | | 10 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | FAS CL E G H | 355 | 11920 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 59 | | |
HP:0002665 | HP:0030080 | Burkitt lymphoma | 2 | FAS CL E G H | 355 | 11920 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 59 | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | FAS CL E G H | 355 | 11920 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 59 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | FASLG CL E G H | 356 | 11936 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 37 | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | FASLG CL E G H | 356 | 11936 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 37 | | |
HP:0002665 | HP:0030080 | Burkitt lymphoma | 2 | FASLG CL E G H | 356 | 11936 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 37 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | FCHO1 CL E G H | 23149 | 29002 | OMIM:619164 | IMMUNODEFICIENCY 76; IMD76 | | | | | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | FOXP1 CL E G H | 27086 | 3823 | ORPHA:52417 | MALT lymphoma | HP:0040281 - Very frequent | | | 184 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | IGH CL E G H | 3492 | 5477 | ORPHA:52417 | MALT lymphoma | HP:0040281 - Very frequent | | | 7 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | IGH CL E G H | 3492 | 5477 | ORPHA:52416 | Mantle cell lymphoma | HP:0040281 - Very frequent | | | 7 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | IKZF3 CL E G H | 22806 | 13178 | OMIM:619437 | IMMUNODEFICIENCY 84; IMD84 | | | | | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | ITK CL E G H | 3702 | 6171 | OMIM:613011 | LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1 | | | | 51 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | MAGT1 CL E G H | 84061 | 28880 | OMIM:300853 | IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN | | | | 17 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | MALT1 CL E G H | 10892 | 6819 | ORPHA:52417 | MALT lymphoma | HP:0040281 - Very frequent | | | 6 | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | MLH1 CL E G H | 4292 | 7127 | OMIM:276300 | Mismatch repair cancer syndrome 1 | | | | 1819 | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | MSH6 CL E G H | 2956 | 7329 | OMIM:619097 | MISMATCH REPAIR CANCER SYNDROME 3; MMRCS3 | | | | 2232 | | |
HP:0002665 | HP:0030080 | Burkitt lymphoma | 2 | MYC CL E G H | 4609 | 7553 | OMIM:113970 | Burkitt lymphoma | . | | | 11 | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | NBN CL E G H | 4683 | 7652 | ORPHA:647 | Nijmegen breakage syndrome | HP:0040283 - Occasional | | | 706 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | NBN CL E G H | 4683 | 7652 | ORPHA:647 | Nijmegen breakage syndrome | HP:0040283 - Occasional | | | 706 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | PIK3R1 CL E G H | 5295 | 8979 | OMIM:616005 | Immunodeficiency 36 | HP:0040284 - Very rare | | | 43 | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | POLE CL E G H | 5426 | 9177 | OMIM:618336 | Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency | HP:0040284 - Very rare | | | 1129 | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | PRKCD CL E G H | 5580 | 9399 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 10 | | |
HP:0002665 | HP:0030080 | Burkitt lymphoma | 2 | PRKCD CL E G H | 5580 | 9399 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 10 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | PRKCD CL E G H | 5580 | 9399 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 10 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | PTPRC CL E G H | 5788 | 9666 | OMIM:619924 | | | | | 25 | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | RASGRP1 CL E G H | 10125 | 9878 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | | | |
HP:0002665 | HP:0030080 | Burkitt lymphoma | 2 | RASGRP1 CL E G H | 10125 | 9878 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | RASGRP1 CL E G H | 10125 | 9878 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | RASGRP1 CL E G H | 10125 | 9878 | OMIM:618534 | IMMUNODEFICIENCY 64; IMD64 | | | | | | |
HP:0002665 | HP:0030080 | Burkitt lymphoma | 2 | RHOH CL E G H | 399 | 686 | OMIM:618307 | Epidermodysplasia verruciformis, susceptibility to, 4 | . | | | | | |
HP:0002665 | HP:0030080 | Burkitt lymphoma | 2 | SH2D1A CL E G H | 4068 | 10820 | OMIM:308240 | Lymphoproliferative syndrome, X-linked, 1 | | | | 37 | | |
HP:0002665 | HP:0012191 | B-cell lymphoma | 2 | SYK CL E G H | 6850 | 11491 | OMIM:619381 | IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD82 | | | | 1 | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | TNFRSF1B CL E G H | 7133 | 11917 | ORPHA:2584 | Classic mycosis fungoides | | | | | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | TNFRSF1B CL E G H | 7133 | 11917 | ORPHA:3162 | Sézary syndrome | | | | | | |
HP:0002665 | HP:0012190 | T-cell lymphoma | 2 | TTC7A CL E G H | 57217 | 19750 | OMIM:243150 | Gastrointestinal defects and immunodeficiency syndrome | | | | 26 | | |
HP:0002665 | HP:0030080 | Burkitt lymphoma | 2 | XIAP CL E G H | 331 | 592 | OMIM:308240 | Lymphoproliferative syndrome, X-linked, 1 | | | | 81 | | |
HP:0002665 | HP:0005517 | T-cell lymphoma/leukemia | 3 | CL E G H | | | | | | | | | | |
HP:0002665 | HP:0034403 | Subcutaneous panniculitis-like T-cell lymphoma | 3 | CL E G H | | | | | | | | | | |
HP:0002665 | HP:0033125 | Follicular lymphoma | 3 | CL E G H | | | | | | | | | | |
HP:0002665 | HP:0012193 | Anaplastic large-cell lymphoma | 3 | CL E G H | | | | | | | | | | |
HP:0002665 | HP:0012192 | Cutaneous T-cell lymphoma | 3 | CD28 CL E G H | 940 | 1653 | ORPHA:2584 | Classic mycosis fungoides | HP:0040282 - Frequent | | | | | |
HP:0002665 | HP:0012192 | Cutaneous T-cell lymphoma | 3 | CD28 CL E G H | 940 | 1653 | ORPHA:3162 | Sézary syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002665 | HP:0012192 | Cutaneous T-cell lymphoma | 3 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:2584 | Classic mycosis fungoides | HP:0040282 - Frequent | | | 10 | | |
HP:0002665 | HP:0012192 | Cutaneous T-cell lymphoma | 3 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:3162 | Sézary syndrome | HP:0040281 - Very frequent | | | 10 | | |
HP:0002665 | HP:0012192 | Cutaneous T-cell lymphoma | 3 | TNFRSF1B CL E G H | 7133 | 11917 | ORPHA:2584 | Classic mycosis fungoides | HP:0040282 - Frequent | | | | | |
HP:0002665 | HP:0012192 | Cutaneous T-cell lymphoma | 3 | TNFRSF1B CL E G H | 7133 | 11917 | ORPHA:3162 | Sézary syndrome | HP:0040281 - Very frequent | | | | | |